Skip to content

Bypass Grafting vs. Endarterectomy for the Treatment of Symptomatic Vertebral Artery Origin Stenosis: A Prospective Cohort Study on Efficacy and Safety

Bypass Grafting vs. Endarterectomy for the Treatment of Symptomatic Vertebral Artery Origin Stenosis: A Prospective Cohort Study on Efficacy and Safety

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095680
Enrollment
Unknown
Registered
2025-01-10
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic Vertebral Artery Origin Stenosis

Interventions

Bypass Grafting group:None
Endarterectomy group:None

Sponsors

The Third Affiliated Hospital of Sun-Yat sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Vertebral artery origin stenosis confirmed by digital subtraction angiography (DSA), magnetic resonance angiography (MRA), or computed tomography angiography (CTA), with stenosis severity >=50%; 2) Age >=18 years; 3) Presence of symptoms (such as dizziness, fatigue, transient ischemic attacks [TIA], stroke-like symptoms, etc.) directly associated with the vertebral artery origin stenosis; 4) Complete clinical records available, including medical history, imaging findings, and laboratory results; 5) Patient willingness to participate in the clinical trial.

Exclusion criteria

Exclusion criteria: 1) Cerebrovascular malformations, moyamoya disease, or similar conditions; 2) Acute intracerebral hemorrhage; 3) History of any surgery related to the vertebral artery or nervous system within the past month; 4) Coexisting severe cardiovascular or pulmonary diseases, liver or renal dysfunction; 5) Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Effect of vascular reconstruction;Improvement of clinical symptoms;Vertebral artery restenosis rate;Recurrence rate of stroke;

Secondary

MeasureTime frame
Incidence of postoperative complications;Postoperative mortality rate;Quality of life;Recovery of neurological function;Postoperative vascular restenosis rate;

Countries

China

Contacts

Public ContactWang Hui

The Third Affiliated Hospital of Sun-Yat sen University

wangh22@mail.sysu.edu.cn+86 137 6332 2020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026